To examine the clinical relevance of DDR1 and ARF6 in HCC, we evaluated the protein and phosphorylation levels of DDR1 and ARF6-GTP in a cohort of 50 paired HCC tissues and peripheral non-tumor tissue samples from Tongji hospital by western blot. This evidence concerns the gene ARF6 and hepatocellular carcinoma.